Balloon catheter with elastomeric sheath and methods

US10086177B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10086177-B2
Application numberUS-201615061121-A
CountryUS
Kind codeB2
Filing dateMar 4, 2016
Priority dateJan 9, 2014
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Balloon catheters that include a balloon and an elastomeric sheath, each having a surface with a therapeutic agent disposed thereon, along with methods of making and methods of using the disclosed balloon catheters.

First claim

Opening claim text (preview).

What is claimed: 1. A method of delivering one or more therapeutic agents to a diseased vessel, the method comprising: providing a balloon catheter comprising: an elongated catheter shaft having proximal and distal ends; a folded inflatable balloon located close to the distal end of the catheter shaft, wherein the balloon comprises a polymeric material having a surface with a first therapeutic agent disposed thereon; and an elastomeric sheath positioned around the folded inflatable balloon such that the inflatable balloon is located within the elastomeric sheath, wherein the sheath comprises an elastomeric material having a surface with a second therapeutic agent disposed thereon; advancing the balloon catheter into the diseased vessel; inflating the folded inflatable balloon to form an inflated balloon and an expanded sheath that contacts the wall of the diseased vessel and thereby delivers the second therapeutic agent from the surface of the expanded sheath to a first site of the diseased vessel; deflating the inflated balloon after delivering the second therapeutic agent to the first site to reform the inflatable balloon into a reformed inflatable balloon; removing the elastomeric sheath from around the reformed inflatable balloon; and inflating the reformed inflatable balloon to contact the wall of the diseased vessel with the first therapeutic agent to deliver the first therapeutic agent from the surface of the inflated reformed inflatable balloon to the first site, or to a different site of the same or a different diseased vessel if the reformed inflatable balloon is moved to the different site after the expanded sheath contacts the wall of the diseased vessel and before inflating the reformed inflatable balloon. 2. The method of claim 1 wherein the balloon catheter further comprises a protective sheath positioned around the elastomeric sheath and the inflatable balloon located in the elastomeric sheath, and the method further comprises removing the protective sheath from the elastomeric sheath after advancing the balloon catheter into the diseased vessel. 3. The method of claim 1 wherein the diseased vessel comprises a vascular lesion having a length that is longer than the length of the balloon. 4. The method of claim 1 wherein removing the elastomeric sheath from around the reformed inflatable balloon comprises retracting the sheath towards the proximal end of the catheter shaft. 5. The method of claim 1 wherein the elastomeric sheath is longer than the inflatable balloon; and wherein after inflating the inflatable balloon to form the inflated balloon and the expanded sheath and prior to removing the elastomeric sheath from around the reformed inflatable balloon, the method comprises: retracting the inflatable balloon proximally towards the proximal end of the catheter shaft within the elastomeric sheath; inflating the inflatable balloon after retracting the inflatable balloon proximally so that the elastomeric sheath contacts the wall of the diseased vessel and thereby delivers the second therapeutic agent to a second site that is located proximally from the first site of the diseased vessel; and deflating the inflated balloon after delivering the second therapeutic agent at the second site. 6. A method of delivering one or more therapeutic agents to a diseased vessel, the method comprising: providing a balloon catheter comprising: an elongated catheter shaft having proximal and distal ends; a folded inflatable balloon located close to the distal end of the catheter shaft, wherein the balloon comprises a polymeric material having a surface with a first therapeutic agent disposed thereon; and an elastomeric sheath positioned around the folded inflatable balloon such that the inflatable balloon is located within the elastomeric sheath, wherein the sheath comprises an elastomeric material having a surface with a second therapeutic agent disposed thereon; advancing the balloon catheter into the diseased vessel; inflating the folded inflatable balloon to form an inflated balloon and an expanded sheath that contacts the wall of the diseased vessel and thereby delivers the second therapeutic agent from the surface of the expanded sheath to a first site of the diseased vessel; deflating the inflated balloon after delivering the second therapeutic agent to the first site to reform the inflatable balloon into a reformed inflatable balloon; removing the elastomeric sheath from around the reformed inflatable balloon, wherein removing the elastomeric sheath from around the reformed inflatable balloon comprises advancing the reformed inflatable balloon to a second site of the diseased vessel that is distal from the first site; and inflating the reformed inflatable balloon to contact the wall of the diseased vessel with the first therapeutic agent to deliver the first therapeutic agent from the surface of the inflated reformed inflatable balloon to the first site, or to a different site of the same or a different diseased vessel if the reformed inflatable balloon is moved to the different site after the expanded sheath contacts the wall of the diseased vessel and before inflating the reformed inflatable balloon. 7. The method of claim 6 wherein the balloon catheter further comprises a protective sheath positioned around the elastomeric sheath and the inflatable balloon located in the elastomeric sheath, and the method further comprises removing the protective sheath from the elastomeric sheath after advancing the balloon catheter into the diseased vessel. 8. The method of claim 6 wherein the diseased vessel comprises a vascular lesion having a length that is longer than the length of the balloon. 9. A method of delivering one or more therapeutic agents to a diseased vessel, the method comprising: providing a balloon catheter comprising: an elongated catheter shaft having proximal and distal ends; an inflatable balloon located close to the distal end of the catheter shaft, wherein the balloon has a proximal end and a distal end, and wherein the balloon comprises a polymeric material having a surface with a first therapeutic agent disposed thereon; an elastomeric sheath positioned around the inflatable balloon such that the inflatable balloon is located within the elastomeric sheath, wherein the sheath comprises an elastomeric material having a surface with a second therapeutic agent disposed thereon, and wherein the elastomeric sheath is longer than the inflatable balloon; and a protective sheath positioned around the elastomeric sheath and the inflatable balloon; advancing the balloon catheter into the diseased vessel; retracting the protective sheath towards the proximal end of the catheter shaft so that the inflatable balloon is not located in the protective sheath; inflating the inflatable balloon to form an inflated balloon and an expanded sheath that contacts the wall of the diseased vessel and thereby delivers the second therapeutic agent from the surface of the expanded sheath to a first site of the diseased vessel; deflating the inflated balloon after delivering the second therapeutic agent to the first site to reform the inflatable balloon into a reformed inflatable balloon; retracting the protective sheath proximally towards the proximal end of the catheter shaft so that the reformed inflatable balloon is not located in the protective sheath after delivering the second therapeutic agent to the first site; retracting the reformed inflatable balloon proximally towards the proximal end of the catheter shaft within the elastomeric sheath; inflating the reformed inflatable balloon so that the elastomeric sheath contacts the wall of the diseased vessel and thereby delivers the second therapeutic agen

Assignees

Inventors

Classifications

  • having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths · CPC title

  • using a temporary backing to which the coating has been applied · CPC title

  • Balloons with folds, e.g. folded or multifolded · CPC title

  • Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface · CPC title

  • characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10086177B2 cover?
Balloon catheters that include a balloon and an elastomeric sheath, each having a surface with a therapeutic agent disposed thereon, along with methods of making and methods of using the disclosed balloon catheters.
Who is the assignee on this patent?
Medtronic Vascular Inc
What technology area does this patent fall under?
Primary CPC classification A61M25/1002. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).